City of Hope Medical Group

Pasadena, California 91105

0 studies enrolling now · 24 studies all time

What they study most

Brain and Central Nervous System Tumors, Breast Cancer, Cancer Survivor, Carcinoma, Non Small Cell Lung, Chronic Myeloproliferative Disorders, Colorectal Cancer, Colorectal Carcinoma, Gastric Cancer, Leukemia, Lung Cancer, Lymphoma, Melanoma

Studies at this site

• Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer — Running, not enrolling
• Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction — Completed
• Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease — Completed
• Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer — Completed
• PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib — Completed
• Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma — Completed
• Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors — Completed
• Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant — Completed
• Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer — Completed
• Dasatinib in Treating Patients With Stage IV Pancreatic Cancer — Stopped early
• Tirapazamine, Carboplatin, and Paclitaxel in Treating Patients With Advanced Malignant Solid Tumors — Completed
• CCI-779 in Treating Patients With Metastatic Melanoma — Completed
• White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors — Completed
• Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment — Stopped early
• Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors — Completed
• SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy — Completed
• Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment — Completed
• Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma — Completed
• Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia — Completed
• MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed
• Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer — Stopped early
• R115777 in Treating Patients With Advanced Solid Tumors — Completed
• UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors — Completed
• Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma — Completed